Credit Agricole’s Greenwich LifeSciences GLSI Stock Holding History

Credit Agricole’s Portfolio GLSI Stock Details GLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-87,000	Closed	-$1.83M	–	1309
2025 Q4	$1.83M	Buy	+87,000	New	+$916K	﹤0.01%	891
2025 Q1	$830K	Hold	87,000	–	–	﹤0.01%	957
2024 Q4	$977K	Hold	87,000	–	–	﹤0.01%	935
2024 Q3	$1.25M	Hold	87,000	–	–	0.01%	732
2024 Q2	$1.5M	Buy	+87,000	New	+$1.27M	0.01%	628

Other funds holding GLSI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Credit Agricole's GLSI Position: Q1 2026 in Review

Credit Agricole sold out of Greenwich LifeSciences (GLSI) in Q1 2026, closing a stake of 87,000 shares — an estimated $1.83M sold.

Credit Agricole first reported a position in GLSI in Q2 2024 and held it in 5 quarters. The position peaked at $1.83M in Q4 2025. 64 funds tracked by Wall St. Rank hold GLSI as of Q1 2026.

Credit Agricole reported no remaining Greenwich LifeSciences position as of Q1 2026 after selling out during the quarter.
Credit Agricole sold 87,000 Greenwich LifeSciences shares in Q1 2026, an estimated $1.83M.
Credit Agricole first reported a position in Greenwich LifeSciences in Q2 2024 and held it in 5 quarters.
Credit Agricole's Greenwich LifeSciences position peaked at $1.83M in Q4 2025.
64 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2026.

Based on Credit Agricole's 13F filing for Q1 2026, filed 15 May 2026.